The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma

References

• Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 1990;336:357–9.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444–51.
   PubMed Web of Science ®Google Scholar
• Nuako KW, Ahlquist DA, Mahoney DW Schaid DJ, Siems DM, Lindor NM. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1998;115:1079–83.
   PubMed Web of Science ®Google Scholar
• Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133:1099–105.
   PubMed Web of Science ®Google Scholar
• Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451–9.
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:314–21.
   PubMed Web of Science ®Google Scholar
• Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51:V10–12.
   PubMed Web of Science ®Google Scholar
• Collins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006:CD000279.
   Google Scholar
• Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634–48.
   PubMed Web of Science ®Google Scholar
• Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931–68.
   PubMed Web of Science ®Google Scholar
• Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 2001;194:152–7.
   PubMed Web of Science ®Google Scholar
• Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003;124:544–60.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71–4.
   PubMed Web of Science ®Google Scholar
• Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 1995;87:1067–71.
   PubMedGoogle Scholar
• Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997;82:4258–65.
   PubMed Web of Science ®Google Scholar
• Cavallini A, Messa C, Pricci M, Caruso ML, Barone M, Di Leo A. Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer. Dig Dis Sci 2002;47:2720–8.
   PubMedGoogle Scholar
• Francavilla A, Di Leo A, Polimeno L, Conte D, Barone M, Fanizza G, et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 1987;93:1301–6.
   PubMed Web of Science ®Google Scholar
• Di Leo A, Messa C, Russo F, Misciagna G, Guerra V, Taveri R, et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig Dis Sci 1994;39:2038–42.
   PubMedGoogle Scholar
• Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes’ staging. Oncol Rep 2005;14:17–21.
   PubMed Web of Science ®Google Scholar
• Fujii S, Tominaga K, Kitajima K, Takeda J, Kusaka T, Fujita M, et al. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis. Gut 2005;54:1287–92.
   PubMed Web of Science ®Google Scholar
• Tominaga K, Fujii S, Mukawa K, Fujita M, Ichikawa K, Tomita S, et al. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis. Clin Cancer Res 2005;11:8880–5.
   PubMed Web of Science ®Google Scholar
• Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 2011;119:92–101.
   Google Scholar
• Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, et al. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 2011;29:4273–8.
   PubMed Web of Science ®Google Scholar
• Lukas M. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis 2010;28:619–24.
   PubMed Web of Science ®Google Scholar
• Sebastian S, Hernández V, Myrelid P, Kariv R, Tsianos E, Toruner M, et al. Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). J Crohns Colitis 2014;8:5–18.
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Lakatos L. Challenges in calculating the risk for colorectal cancer in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2012;10:1179.
   Google Scholar
• Reenaers C, Belaiche J, Louis E. Impact of medical therapies on inflammatory bowel disease complication rate. World J Gastroenterol 2012;18:3823–7.
   Google Scholar
• Andersen NN, Jess T. Has the risk of colorectal cancer in inflammatory bowel disease decreased? World J Gastroenterol 2013;19:7561–8.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1–33.
   PubMed Web of Science ®Google Scholar
• Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 2004;64:423–8.
   PubMed Web of Science ®Google Scholar
• Planey SL, Kumar R, Arnott JA. Estrogen receptors (ERα versus ERβ): friends or foes in human biology? J Recept Signal Transduct Res 2014;34:1–5.
   PubMed Web of Science ®Google Scholar
• Kerdivel G, Flouriot G, Pakdel F. Modulation of estrogen receptor alpha activity and expression during breast cancer progression. Vitam Horm 2013;93:135–60.
   PubMed Web of Science ®Google Scholar
• Di Leo A, Barone M, Maiorano E, Tanzi S, Piscitelli D, Marangi S, et al. ER-beta expression in large bowel adenomas: implications in colon carcinogenesis. Dig Liver Dis 2008;40:260–6.
   PubMedGoogle Scholar
• Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, et al. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Carcinogenesis 2010;31:269–74.
   PubMed Web of Science ®Google Scholar
• Principi M, Di Leo A, Pricci M, Scavo MP, Guido R, Tanzi S, et al. Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study. World J Gastroenterol 2013;19:4325–33.
   PubMed Web of Science ®Google Scholar
• Hardy RG, Meltzer SJ, Jankowski JA. ABC of colorectal cancer. Molecular basis for risk factors. BMJ 2000;321:886–9.
   Google Scholar
• Tanaka T. Development of an inflammation-associated colorectal cancer model and its application for research on carcinogenesis and chemoprevention. Int J Inflam 2012;2012:658786.
   PubMedGoogle Scholar
• Principi M, De Tullio N, Scavo MP, Piscitelli D, Marzullo A, Russo S, et al. Estrogen receptors expression in long-lasting ulcerative pancolitis with and without dysplasia: a preliminary report. Scand J Gastroenterol 2012;47:1253–4.
   PubMed Web of Science ®Google Scholar
• Principi M, Barone M, Pricci M, De Tullio N, Losurdo G, et al. Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role? World J Gastroenterol 2014;20:11496–504.
   Google Scholar
• Barone M, Scavo MP, Papagni S, Piscitelli D, Guido R, Di Lena M, et al. ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis. Scand J Gastroenterol 2010;45:1320–8.
   PubMed Web of Science ®Google Scholar
• Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001;61:632–40.
   PubMed Web of Science ®Google Scholar
• Jiang H, Teng R, Wang Q, Zhang X, Wang H, Wang Z, et al. Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues. J Steroid Biochem Mol Biol 2008;112:20–4.
   Web of Science ®Google Scholar
• Armstrong CM, Billimek AR, Allred KF, Sturino JM, Weeks BR, Allred CD. A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formation. Endocr Relat Cancer 2013;20:515–25.
   Google Scholar
• Hsu HH, Cheng SF, Chen LM, Liu JY, Chu CH, Weng YJ, et al. Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells. Mol Cell Biochem 2006;289:101–9.
   Google Scholar
• Arasaradnam RP, Khoo K, Bradburn M, Mathers JC, Kelly SB. DNA methylation of ESR-1 and N-33 in colorectal mucosa of patients with ulcerative colitis (UC). Epigenetics 2010;5:422–6.
   PubMed Web of Science ®Google Scholar